Therapeutic applications of antisense DNA in the treatment of human leukemia

Related Experiment Videos

¹Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia 19104.

Annals of the New York Academy of Sciences

|October 28, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effect of Interleukin-1 α and Interleukin-1 β on Erythroid Progenitor Cell Growth in Serum Free Cultures: An In Vitro Study Relevant to the Pathogenesis of the Anemia of Chronic Disease.

Hematology (Amsterdam, Netherlands)·2016

Delivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting.

Gene therapy·2006

Progress in the development of nucleic acid therapeutics.

Handbook of experimental pharmacology·2006

2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (2'F-ANA) modified oligonucleotides (ON) effect highly efficient, and persistent, gene silencing.

Nucleic acids research·2006

Rationally targeted, conformationally constrained, oxetane-modified oligonucleotides demonstrate efficient gene-silencing activity in a cellular system.

Annals of the New York Academy of Sciences·2006

Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules.

Nucleic acids research·2004

See all related articles